» Articles » PMID: 34336716

CbpF Mediates Inhibition of T Cell Function Through CEACAM1 Activation

Abstract

is an anaerobic bacterium that is associated with several tumor entities and promotes tumorigenesis. Recent evidence suggests that binds the inhibitory receptor carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) the trimeric autotransporter adhesin CbpF. However, whether this binding is functional or whether other fusobacterial trimeric autotransporter adhesins are involved in CEACAM1 activation is unknown. In this study, using mutants lacking the type 5c trimeric autotransporter adhesins fvcA (CbpF), fvcB, fvcC, and fvcD, we show that CbpF binds and activates CEACAM1 and also binds carcinoembryonic antigen (CEA), a tumor-associated protein. We further find that CEACAM antibodies directed against the CEACAM N-terminal domain block the CbpF-CEACAM1 interaction. In functional assays, we demonstrate CbpF-dependent inhibition of CD4 T cell response. Thus, we characterize an immune evasion mechanism in which uses its surface protein CbpF to inhibit T cell function by activating CEACAM1.

Citing Articles

Unraveling the Role of in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights.

Galasso L, Termite F, Mignini I, Esposto G, Borriello R, Vitale F Cancers (Basel). 2025; 17(3).

PMID: 39941737 PMC: 11816155. DOI: 10.3390/cancers17030368.


The emerging role of Fusobacteria in carcinogenesis.

Gibbs R, Chambers A, Hill D Eur J Clin Invest. 2024; 54 Suppl 2:e14353.

PMID: 39674881 PMC: 11646295. DOI: 10.1111/eci.14353.


The role of CEACAMs in neutrophil function.

Skubitz K Eur J Clin Invest. 2024; 54 Suppl 2:e14349.

PMID: 39674879 PMC: 11646290. DOI: 10.1111/eci.14349.


Evolution of CEACAM pathogen decoy receptors in primates.

Zimmermann W, Kammerer R Eur J Clin Invest. 2024; 54 Suppl 2:e14356.

PMID: 39674876 PMC: 11646289. DOI: 10.1111/eci.14356.


Current investigation of carcinoembryonic antigen cell adhesion molecule (CEACAM) biology summary of the 32nd CEA symposium: 20-23 September 2024. Würzburg, Germany.

Fleckenstein J, Najjar S, Zimmermann W, Hauck C, Nguyen Q, Mejias-Luque R Eur J Clin Invest. 2024; 54 Suppl 2:e14355.

PMID: 39674873 PMC: 11880994. DOI: 10.1111/eci.14355.


References
1.
Van Sorge N, Bonsor D, Deng L, Lindahl E, Schmitt V, Lyndin M . Bacterial protein domains with a novel Ig-like fold target human CEACAM receptors. EMBO J. 2021; 40(7):e106103. PMC: 8013792. DOI: 10.15252/embj.2020106103. View

2.
Hill D, Toleman M, Evans D, Villullas S, van Alphen L, Virji M . The variable P5 proteins of typeable and non-typeable Haemophilus influenzae target human CEACAM1. Mol Microbiol. 2001; 39(4):850-62. DOI: 10.1046/j.1365-2958.2001.02233.x. View

3.
Bullman S, Pedamallu C, Sicinska E, Clancy T, Zhang X, Cai D . Analysis of persistence and antibiotic response in colorectal cancer. Science. 2017; 358(6369):1443-1448. PMC: 5823247. DOI: 10.1126/science.aal5240. View

4.
Brewer M, Dymock D, Brady R, Singer B, Virji M, Hill D . spp. target human CEACAM1 via the trimeric autotransporter adhesin CbpF. J Oral Microbiol. 2019; 11(1):1565043. PMC: 6346709. DOI: 10.1080/20002297.2018.1565043. View

5.
Berger C, Billker O, Meyer T, Servin A, Kansau I . Differential recognition of members of the carcinoembryonic antigen family by Afa/Dr adhesins of diffusely adhering Escherichia coli (Afa/Dr DAEC). Mol Microbiol. 2004; 52(4):963-83. DOI: 10.1111/j.1365-2958.2004.04033.x. View